LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy
Authors
Keywords
Diffuse large B cell lymphoma, Long noncoding RNAs, LincRNA-p21, Prognosis, Biomarker
Journal
CLINICAL AND EXPERIMENTAL MEDICINE
Volume 17, Issue 1, Pages 1-8
Publisher
Springer Nature
Online
2015-10-16
DOI
10.1007/s10238-015-0396-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma
- (2015) Shiyu Feng et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer
- (2015) Wei Peng et al. TUMOR BIOLOGY
- Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes
- (2015) J R Hall et al. Cell Death & Disease
- Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era
- (2014) R. Vaidya et al. ANNALS OF ONCOLOGY
- Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
- (2014) Yunfei Hu et al. Cancer Cell International
- Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients?
- (2014) Young Wha Koh et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- URG11 predicts poor prognosis of pancreatic cancer by enhancing epithelial–mesenchymal transition-driven invasion
- (2014) Wei Peng et al. MEDICAL ONCOLOGY
- Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer
- (2014) Wei Peng et al. MEDICAL ONCOLOGY
- LincRNA-p21 Activates p21 In cis to Promote Polycomb Target Gene Expression and to Enforce the G1/S Checkpoint
- (2014) Nadya Dimitrova et al. MOLECULAR CELL
- LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway
- (2014) GUANGYU WANG et al. ONCOLOGY REPORTS
- Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
- (2014) Minna Taskinen et al. PLoS One
- Diffuse large B-cell lymphoma
- (2013) Maurizio Martelli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Polycomb protein EZH2 expression in diffuse large B-cell lymphoma is associated with better prognosis in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
- (2013) Hyun Jung Lee et al. LEUKEMIA & LYMPHOMA
- Diffuse large B-cell lymphoma—treatment approaches in the molecular era
- (2013) Mark Roschewski et al. Nature Reviews Clinical Oncology
- LincRNA-p21 Suppresses Target mRNA Translation
- (2012) Je-Hyun Yoon et al. MOLECULAR CELL
- Long Intergenic Noncoding RNAs: New Links in Cancer Progression
- (2011) M.-C. Tsai et al. CANCER RESEARCH
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
- (2010) M.-C. Tsai et al. SCIENCE
- Evolution and Functions of Long Noncoding RNAs
- (2009) Chris P. Ponting et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now